Exact Mass: 660.2206656000001
Exact Mass Matches: 660.2206656000001
Found 61 metabolites which its exact mass value is equals to given mass value 660.2206656000001,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
2)-rhamnoside
2''-O-Rhamnosylicariside II is a flavonoid glycoside compound and might be beneficial for improving postmenopausal osteoporosis.
Calyflorenone A
4-[6-O-(5-O-(dimethoxycinnamic acid)-beta-apiofuranosyl)-beta-glucopyranoside]-5-methylcoumarin
12-O-desacetyl-12-O-benzoylpteroidine
C34H41ClO11 (660.2337266000001)
3-O--catechin-<5,6-e>-4beta-(3,4-dihydroxyphenyl)-dihydro-2(3H)-pyranone
2-O-RHAMNOSYLICARISIDE II
2''-O-Rhamnosylicariside II is a flavonoid glycoside compound and might be beneficial for improving postmenopausal osteoporosis.
5-hydroxy-7-(4-hydroxyphenyl)-2-methyl-2-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxymethyl]pyrano[3,2-g]chromen-6-one
2,7-Bis(9H-fluoren-2-yl)-4,9-diphenylpyrido[2,3-g]quinoline
(-)-1,2-BIS((2R,5R)-2,5-DIETHYLPHOSPHOLANO)BENZENE(CYCLOOCTADIENE)RHODIUM(L)TETRAFLUOROBORATE
C30H48BF4P2Rh (660.2315275999999)
butane-1,4-diol,1,3-diisocyanato-2-methylbenzene,hexanedioic acid,1-isocyanato-4-[(4-isocyanatophenyl)methyl]benzene
Hexafluronium Bromide
C36H42Br2N2 (660.1714532000001)
D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents > D006584 - Hexamethonium Compounds D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists C78272 - Agent Affecting Nervous System > C29698 - Antispasmodic Agent C471 - Enzyme Inhibitor > C47792 - Acetylcholinesterase Inhibitor
(11bR)-2,6-Bis([1,1-biphenyl]-4-yl)-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1,2-f][1,3,2]dioxaphosphepin
1-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-2-[[(4-methoxy-3-methylphenyl)sulfonyl-methylamino]methyl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(1-naphthalenyl)urea
alpha-D-glucopyranosyl-(1->3)-6-deoxy-alpha-L-mannopyranosyl-(1->2)-6-deoxy-alpha-L-mannopyranosyl-(1->3)-2-O-acetyl-6-deoxy-alpha-L-mannopyranose
5-hydroxy-7-(4-hydroxyphenyl)-2-methyl-2-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxymethyl]pyrano[3,2-g]chromen-6-one
Elloramycin A
A member of the class of tetracenomycins that is 8-demethyltetracenomycin C in which the hydroxyl hydrogens at position 8 and 10 a are replaced by a 2,3,4-tri-O-methyl-alpha-L-rhamnosyl and methyl groups respectively.
6,12-bis(3,4-dihydroxyphenyl)-8-hydroxy-4-oxo-3,11-dioxatricyclo[8.4.0.0²,⁷]tetradeca-1,7,9-trien-13-yl 5-(3,4-dihydroxyphenyl)-3-hydroxypentanoate
(2e)-8-[(3r,4s,5r)-3-(acetyloxy)-5-{[(2e)-8-[(1s,5r,6s)-5-(acetyloxy)-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-2-methyl-6-methylideneoct-2-en-7-ynoyl]oxy}-4-hydroxy-6-oxocyclohex-1-en-1-yl]-2-methyl-6-methylideneoct-2-en-7-ynoic acid
n-{4-[(3s)-19-{[(2s,4s,5r)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-11-hydroxy-9-methyl-4,14,21-trioxo-5-oxa-2-azapentacyclo[11.8.0.0²,⁶.0⁷,¹².0¹⁵,²⁰]henicosa-1(13),7,9,11,15,17,19-heptaen-3-yl]butyl}-2,2,2-trifluoroethanimidic acid
18-(acetyloxy)-20-(furan-3-yl)-2,3,4-trihydroxy-5,14,19-trimethyl-8,22-dioxo-9,13,15,21,25-pentaoxaoctacyclo[12.10.1.1⁵,¹².0¹,¹⁶.0³,¹².0⁶,¹¹.0¹¹,¹⁶.0¹⁹,²⁴]hexacosan-17-yl acetate
(2s,3r,4s,5s,6r)-2-(4-{4-[(1e)-2-(3,5-dihydroxyphenyl)ethenyl]phenoxy}-2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenoxy)-6-(hydroxymethyl)oxane-3,4,5-triol
4-{2-hydroxy-4-[2-methoxy-3,5,6-trimethyl-4-(sulfooxy)benzoyloxy]-3,5,6-trimethylbenzoyloxy}-2-methoxy-3,5,6-trimethylbenzoic acid
C32H36O13S (660.1876526000001)
6-{[(2r)-6,11-dihydroxy-2,5-dimethyl-10-oxo-1-oxa-5-azatetraphen-2-yl]methoxy}-7,11-dihydroxy-2,2,5-trimethyl-1-oxa-5-azatetraphen-10-one
C38H32N2O9 (660.2107702000001)